期刊文献+

中试生产的结核DNA疫苗免疫效能研究 被引量:1

Immune efficacy of tuberculosis DNA vaccine produced by magnifying technology
暂未订购
导出
摘要 目的以300L发酵罐中试规模生产的冻干Mtb Ag85A质粒DNA疫苗为基础免疫小鼠,对该疫苗的免疫效能进行研究。方法将4~6周龄的BALB/c小鼠20只通过数字表法随机分为2组,一组免疫MtbAg85A质粒DNA疫苗(结核DNA疫苗免疫组),另一组免疫PBS作为阴性对照(PBS对照组);于免疫前采血,肌内注射免疫3次。在第3次免疫后3周摘眼球处死小鼠,收集血清,进行血清特异性抗体检测和细胞因子(IFN-γ、IL-4)检测;同时对每只小鼠取脾细胞进行特异性γ干扰素(IFN-γ)分泌检测和脾细胞CD4+、CD8+百分率检测。结果 (1)免疫前后免疫组与对照组抗体水平吸光度A值均小于0.2。(2)结核DNA疫苗免疫组血清细胞因子IL-4水平[(146.2±34.3)pg/ml]低于PBS对照组[(177.7±28.1)pg/ml],差异有统计学意义(t=2.244,P=0.038),而IFN-γ水平[(129.6±159.0)pg/ml]虽然高于PBS对照组[(76.5±21.5)pg/ml],但差异无统计学意义(t=-1.047,P=0.309)。(3)酶联免疫斑点检测结果表明结核DNA疫苗免疫组脾细胞特异性IFN-γ分泌水平(分泌IFN-γ细胞个数)(103.60±112.14)高于PBS对照组(5.78±5.83),差异有统计学意义(t=36.538,P=0.018)。(4)结核DNA疫苗免疫组CD4+细胞百分率均值(21.57%)高于PBS对照组(12.17%),差异有统计学意义(t=3.043,P=0.038);CD8+细胞百分率均值(13.70%)与PBS对照组(10.57%)相比,差异无统计学意义(t=0.847,P=0.445)。结论Mtb Ag85A质粒DNA疫苗主要刺激机体Th1型细胞免疫,而对诱导机体产生Th2型细胞免疫应答没有显著的促进作用。 Objective To study the immunogenicity of Mycobacterial tuberculosis Ag85A DNA vaccine with pilot scale production in mice.Methods Twenty BALB/c mice were randomly divided into 2 groups,and then immunized intramuscularly for 3 times with Mtb Ag85A DNA or PBS respectively.The mice were killed and the whole blood samples were collected at 3 weeks after the last immunization.The specific antibody and cytokines(IL-4) in sera were detected.The Mtb Ag85A specific interferon-γ(IFN-γ) level and the percentages of CD4+ or CD8+ T cell in mouse spleen cells were also detected.Results The data obtained by statistical analyses demonstrated that:(1) The absorbance values of Ag85A-specific antibody in the sera of each group mice before and after immunization were all less than 0.2.(2) The IL-4 level in sera from Ag85A DNA group [(146.2±34.3) pg/ml] was significantly lower than that from PBS group [(177.7±28.1) pg/ml](t=2.244,P=0.038).The IFN-γ level in sera from Ag85A DNA group [(129.6±159.0) pg/ml]was higher than that from PBS group [(76.5±21.5) pg/ml],but there was no significant difference(t=-1.047,P=0.309).(3) The data from the ELISPOT assay for IFN-γ showed that the number of spot-forming spleen cells in Ag85A DNA group(103.60±112.14) was significantly higher than that in PBS group(5.78±5.83)(t=36.538,P=0.018).(4) The percentage(21.57%) of CD4+ T cells in Ag85A DNA group was higher than that(12.17%) in PBS group(t=3.043,P=0.038);however,there was no significant difference on the percentage of CD8+ T cells between the two groups(13.70% vs.10.57%,t=0.847,P=0.445).Conclusion The Th1 cellular immunity was mainly stimulated in the mice immunized by Mtb Ag85A DNA vaccine.But Th2 cellular immune response was not significantly induced in these mice.
出处 《中国防痨杂志》 CAS 2012年第3期168-171,共4页 Chinese Journal of Antituberculosis
基金 "十一五"国家科技重大专项(2008ZX-10003-013(2))
关键词 疫苗 DNA 酰基转移酶类 抗原 细菌 免疫活性 Vaccines DNA Acyltransferases Antigens bacterial Immunocompetence
  • 相关文献

参考文献11

  • 1Kozak M. At least six nucleotide preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol, 1987, 196(4):947-950.
  • 2Suarez DL, Schultz-Cherry S. The effect of eukaryotic expres sion vectors and adjuvant on DNA vaccines in chickens using an avian influenza model. Avian Dis, 2000, 44(4):861-868.
  • 3Frelin L, Ahl6n G, Alheim M, et al. Codon optimization and mRNA amplification effectively enhances the immunogenieity of the hepatitis C virus nonstructural 3/4A gene. Gene Ther, 2004, 11(6): 522-533.
  • 4刘国霞,姜宇,张斌,张煜,柳絮,范仲学,钱凤芹.动物核酸疫苗研究进展[J].动物医学进展,2005,26(9):34-36. 被引量:3
  • 5Iwasaki A, Medzhitov R. Toll like receptor control of the adaptive immune responses. Nat Immunol, 2004, 5 (10) : 987 995.
  • 6McNeela EA, Jabbal-Gill I, Illum L, et al. Intranasal immu- nization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan. Vaccine, 2004, 22(8):909 -914.
  • 7孙树汉.核酸疫苗及其在疾病免疫防治中的应用[J].第二军医大学学报,2000,21(6):519-521. 被引量:15
  • 8Gallichan WS, Rosenthal KL. I.ong-term immunity and pro teetion against herpes simplex virus type 2 in the murine fe- male genital tract after mucosal but not systemic immuniza- tion. J Infect Dis, 1998, 177(5): 1155-1161.
  • 9McCluskie MJ, Brazolot Millan CL, Gramzinski RA, et al. Route and method of delivery of DNA vaccine influence im mune responses in mice and non-human primates. Mol Med, 1999,5(5): 287- 300.
  • 10Wang R, Doolan DL, I.e TP, et al. Induction of antigen-spe- cific cyto'Loxic T lymphocytes in humans by a malaria DNA vaccine. Science, 1998, 282(5388): 476-480.

二级参考文献21

  • 1姜永萍,于康震,邓国华,田国斌,乔传玲,陈化兰.表达H5亚型禽流感病毒HA基因的DNA疫苗免疫保护效力研究[J].中国农业科学,2004,37(7):1071-1075. 被引量:11
  • 2Krieg A M,Nature,1995年,374卷,6522期,546页
  • 3Tang C,Nature,1992年,35 6卷,6365期,152页
  • 4Cohen J. Naked DNA points way to vaccines[J]. Science, 1993,259:1691-1692.
  • 5Zijl M, Wensvoort G, Kluyver W, et al. Live attenuated pseudorabies virus expressing envelope glycoprotin E1 of hog cholera virus protects swine against both pseudorabies and hot cholera[J]. J Virol, 1991, 65:2761-2765.
  • 6Suarez D L,Cherry S.The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model[J].Avian Dis,2000,44(4):861-868.
  • 7Garg S, Oran A E, Hon H, et al.The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines[J].J Immunol,2004 ,173(1):550-558.
  • 8Van Rooij E M A, Glansbeek H L, Hilgers L A T, et al.Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant[J].J Virol,2002,76(20): 10540-10545.
  • 9Arrington J, Braun R P, Dong L, et al.Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines[J].J Virol,2002 ,76(9): 4536-4546.
  • 10Klinman D M, Yi A K, Beaucage S L, et al. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon[J].Immunology,1996,93( 7): 2879-2883.

共引文献16

同被引文献7

  • 1中国疾病预防控制中心.中国结核病防治规划实施工作指南.北京:中国协和医科大学出版社,2009.55-56.
  • 2中华人民共和国卫生部编.全国结核病耐药性基线调查报告(2007-2008年)北京:人民卫生出版社,2010.23-57.
  • 3Raviglione MC,Smith IM.XDR tu-ber culosis implications for global public health.N EnglJ Med,2007,356(7):656-659.
  • 4Haydel SE. Extensively drug resistant tu-ber culosis:a sign of the times and an impetus for antimicrobial discovery.Pharmaceuticals( Basel),2010,3(7):268-2290.
  • 5肖和平.耐药结核病化学治疗指南(2009)[J].中国防痨杂志,2010,32(4):181-198. 被引量:142
  • 6苏俊华,梁桂亮,保凌,杨惠仙,李晓非,段志妹.昆明地区结核分枝杆菌标本培养检测及耐药情况分析[J].中国防痨杂志,2012,34(1):32-35. 被引量:18
  • 7钟球,钱明,李建伟,陈启亮,卓文基,江勇,黄树智,陈燕梅.广东省WHO结核病耐药监测研究[J].中国防痨杂志,2001,23(1):5-8. 被引量:91

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部